New protease inhibitors prevent γ-secretase-mediated production of Aβ40/42 without affecting Notch cleavage

被引:174
作者
Petit, A
Bihel, F
da Costa, CA
Pourquié, O
Checler, F
Kraus, JL
机构
[1] CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France
[2] Univ Mediterranee, Fac Sci Luminy, Lab Chim Biomol, Marseille, France
[3] LGPD, Unite Mixte Rech 6545, Marseille, France
关键词
D O I
10.1038/35074581
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have designed new non-peptidic potential inhibitors of gamma -secretase and examined their ability to prevent production of amyloid-beta 40 (A beta 40) and A beta 42 by human cells expressing wild-type and Swedish-mutant beta -amyloid precursor protein (beta APP). Here we identify three such agents that markedly reduce recovery of both A beta 40 and A beta 42 produced by both cell lines, and increase that of C99 and C83, the carboxy-terminal fragments of beta APP that are derived from beta -and alpha -secretase, respectively, Furthermore, we show that these inhibitors do not affect endoproteolysis of endogenous or overexpressed presenilins. These inhibitors are totally unable to affect the m Delta Enotch-1 cleavage that leads to generation of the Notch intracellular domain (NICD). These represent the first non-peptidic inhibitors that are able to prevent gamma -secretase cleavage of beta APP without affecting processing of m Delta Enotch-1 or endoproteolysis of presenilins. The distinction between these two proteolytic events, which are both prevented by disruption of presenilin genes, indicates that although they are intimately linked with beta APP and Notch maturation, presenilins are probably involved in the control of maturation processes upstream of enzymes that cleave gamma -secretase and Notch.
引用
收藏
页码:507 / 511
页数:5
相关论文
共 30 条
[1]   Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715→Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease [J].
Ancolio, K ;
Dumanchin, C ;
Barelli, H ;
Warter, JM ;
Brice, A ;
Campion, D ;
Frébourg, T ;
Checler, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :4119-4124
[2]   NOTCH SIGNALING [J].
ARTAVANISTSAKONAS, S ;
MATSUNO, K ;
FORTINI, ME .
SCIENCE, 1995, 268 (5208) :225-232
[3]   Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases [J].
Barelli, HL ;
Lebeau, A ;
Vizzavona, J ;
Delaere, P ;
Chevallier, N ;
Drouot, C ;
Marambaud, P ;
Ancolio, K ;
Buxbaum, JD ;
Khorkova, O ;
Heroux, J ;
Sahasrabudhe, S ;
Martinez, J ;
Warter, JM ;
Mohr, M ;
Checler, F .
MOLECULAR MEDICINE, 1997, 3 (10) :695-707
[4]   Aspartate mutations in presenilin and γ-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservation of Notch1 signaling [J].
Berezovska, O ;
Jack, C ;
McLean, P ;
Aster, JC ;
Hicks, C ;
Xia, WM ;
Wolfe, MS ;
Kimberly, WT ;
Weinmaster, G ;
Selkoe, DJ ;
Hyman, BT .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (02) :583-593
[5]   Maturation and pro-peptide cleavage of β-secretase [J].
Capell, A ;
Steiner, H ;
Willem, M ;
Kaiser, H ;
Meyer, C ;
Walter, J ;
Lammich, S ;
Multhaup, G ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) :30849-30854
[6]   Presenilins - Structural aspects and posttranslational events [J].
Checler, F .
MOLECULAR NEUROBIOLOGY, 1999, 19 (03) :255-265
[7]   Alzheimer's disease:: Correlation of the suppression of β-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome [J].
Christie, G ;
Markwell, RE ;
Gray, CW ;
Smith, L ;
Godfrey, F ;
Mansfield, F ;
Wadsworth, H ;
King, R ;
McLaughlin, M ;
Cooper, DG ;
Ward, RV ;
Howlett, DR ;
Hartmann, T ;
Lichtenthaler, SF ;
Beyreuther, K ;
Underwood, J ;
Gribble, SK ;
Cappai, R ;
Masters, CL ;
Tamaoka, A ;
Gardner, RL ;
Rivett, AJ ;
Karran, EH ;
Allsop, D .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (01) :195-204
[8]   Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF [J].
Citron, M ;
Diehl, TS ;
Capell, A ;
Haass, C ;
Teplow, DB ;
Selkoe, DJ .
NEURON, 1996, 17 (01) :171-179
[9]   Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities [J].
Citron, M ;
Diehl, TS ;
Gordon, G ;
Biere, AL ;
Seubert, P ;
Selkoe, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13170-13175
[10]   An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos [J].
Davis, JA ;
Naruse, S ;
Chen, H ;
Eckman, C ;
Younkin, S ;
Price, DL ;
Borchelt, DR ;
Sisodia, SS ;
Wong, PC .
NEURON, 1998, 20 (03) :603-609